CRL COO Girshick Birgit buys 1,514 shares at $164.63; stock down 33.5% from 52-week high and -3.1% in 30 days.
Girshick Birgit, Corporate Executive VP & COO, purchased 1,514 shares of Charles River Laboratories at $164.63 on 2025-02-20, increasing her holdings by 2.8% to 55,058 shares. The purchase occurs as the stock has declined 33.5% from its 52-week high of $245.29 and fallen 3.1% over the past 30 days, trading at $163.02 currently. Her cross-ticker track record shows 1 prior buy with a 90-day return of +30.4%, and her single prior buy at CRL on 2023-11-20 also generated a +30.4% 90-day return. The company's fundamentals show declining annual revenue growth at -1.9%, a steeply elevated P/E of 815.10, and a market cap of $8.3B against quarterly revenue of $1.0B, suggesting a disconnect between current valuation and near-term earnings power.